Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push

Investing.comFriday, October 10, 2025 at 1:42:48 PM
Bristol Myers buys Orbital Therapeutics for $1.5 billion in cell therapy push
Bristol Myers Squibb has made a significant move in the biotech sector by acquiring Orbital Therapeutics for $1.5 billion. This acquisition is a strategic step to enhance their cell therapy portfolio, which is crucial for addressing various diseases. It highlights Bristol Myers' commitment to innovation and growth in the field of advanced therapies, potentially leading to groundbreaking treatments for patients.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reports
NegativeFinancial Markets
Novo Nordisk has decided to halt its work on a promising cell therapy aimed at treating diabetes, a move that has raised concerns in the medical community. This decision, reported by Bloomberg News, is part of a broader cost-cutting strategy within the company. The implications of this halt are significant, as it may delay advancements in diabetes treatment and affect patients who are eagerly awaiting new options. The decision highlights the challenges pharmaceutical companies face in balancing innovation with financial sustainability.
Novo Nordisk halts cell therapy work for diabetes as part of cost cuts
NegativeFinancial Markets
Novo Nordisk has decided to halt its cell therapy research aimed at treating diabetes as part of a broader cost-cutting strategy. This decision is significant as it reflects the challenges pharmaceutical companies face in balancing innovation with financial sustainability. The cessation of this promising research could delay advancements in diabetes treatment, impacting patients who rely on new therapies for better management of their condition.
Adicet Bio’s SWOT analysis: cell therapy stock faces pivotal moment
NeutralFinancial Markets
Adicet Bio is at a crucial juncture as it navigates the complexities of the cell therapy market. The company's recent SWOT analysis highlights its strengths, weaknesses, opportunities, and threats, providing insights into its potential for growth and challenges ahead. This analysis is significant as it helps investors and stakeholders understand the company's position and future prospects in a rapidly evolving industry.
Latest from Financial Markets
White House Signals Federal Layoffs Have Begun Amid Government Shutdown
NegativeFinancial Markets
The White House has indicated that federal layoffs have started as a result of the ongoing government shutdown. This situation is concerning as it not only affects the livelihoods of federal employees but also has broader implications for government services and the economy. The shutdown highlights the urgent need for a budget agreement to prevent further disruptions and ensure that essential services continue to operate.
Can I Take Batteries on a Plane? What to Know Before You Fly.
NeutralFinancial Markets
Traveling with batteries can be tricky, especially with the recent changes in regulations. This article breaks down what you need to know about taking items like power banks and cordless hair dryers on a plane. Understanding these rules is crucial for a smooth travel experience, ensuring you don’t face any surprises at security checkpoints.
White House lays off thousands of US government workers, blaming shutdown
NegativeFinancial Markets
The White House has announced significant layoffs affecting thousands of US government workers, attributing the decision to the ongoing government shutdown. This move raises concerns about the impact on public services and the livelihoods of those affected. As the shutdown continues, the implications for federal operations and employee morale are becoming increasingly serious, highlighting the urgent need for a resolution.
First Brands boss weighs resigning under pressure from lenders
NegativeFinancial Markets
The CEO of First Brands is contemplating resignation due to mounting pressure from lenders, following the company's swift decline. This situation has sparked worries about potential widespread financial losses on Wall Street, highlighting the interconnectedness of corporate health and market stability. Investors are closely watching how this unfolds, as it could signal broader economic implications.
Gloria Trevi​ Unfiltered Docuseries​ ​’Sin Filtro​' Premieres On ViX
PositiveFinancial Markets
Gloria Trevi, the iconic 'Queen of Mexican Pop,' has premiered her docuseries 'Sin Filtro' on ViX, offering fans a rare glimpse into her life during the 'Mi Soundtrack' world tour. This series is significant as it not only showcases her musical journey but also reveals the personal experiences that shape her artistry, making it a must-watch for fans and newcomers alike.
US threatens visa restrictions, sanctions against UN members that back IMO emissions plan
NegativeFinancial Markets
The United States has issued a stern warning about potential visa restrictions and sanctions against United Nations members who support the International Maritime Organization's emissions plan. This move highlights the U.S. government's commitment to addressing climate change, but it also raises concerns about international cooperation and the potential backlash from countries that may feel pressured. The implications of this stance could affect diplomatic relations and global efforts to combat environmental issues.